… Transcatheter left atrial appendage (LAA) closure is an alternative strategy for stroke
prevention in atrial fibrillation (AF) patients with contraindications for long-term anticoagulant …

… Percutaneous left atrial appendage closure (LAAC) is noninferior to vitamin K antagonists
(VKAs) for preventing atrial fibrillation (AF)–related stroke. However, direct oral anticoagulants (…

… outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure
… , bleeding, and mortality for patients implanted with a WATCHMAN in routine daily practice. …

… atrial appendage occlusion (LAAO) during surgical ablation has emerged as a potential
treatment strategy to reduce stroke and perioperative mortality in patients with atrial fibrillation (…

… Forest plots of the meta-analysis comparing the clinical outcomes after left atrial appendage
occlusion in patients with or without chronic kidney disease. Patients with CKD exhibited …

… Mechanical occlusion of the LAA with a permanently implanted … patients with non-valvular
AF. Several percutaneous devices have been proposed to obtain left atrial appendage closure …

… With Atrial Fibrillation) was conducted to determine whether percutaneous left atrial appendage
closure … (Watchman) was noninferior to warfarin for stroke prevention in atrial fibrillation. …

… Studies have demonstrated the safety and efficacy of left atrial appendage closure (LAAC)
to reduce the risk of stroke in patients with atrial fibrillation, 11 , 12 , 13 and current guidelines …

… therapy (OAT) in patients with atrial fibrillation (AF), and AF patients with previous ICH are a
… Left atrial appendage (LAA) occlusion has emerged as an alternative option for AF patients …

… of a left atrial appendage occlusion device?: A case with implications for percutaneous
transcatheter left atrial appendage occlusion device therapy". Heart Rhythm 2007; 4: 648. …